Your browser doesn't support javascript.
loading
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.
Bolli, Geremia B; Cheng, Alice; Charbonnel, Bernard; Aroda, Vanita R; Westerbacka, Jukka; Bosnyak, Zsolt; Boëlle-Le Corfec, Emmanuelle; Rosenstock, Julio.
Afiliação
  • Bolli GB; Department of Medicine, Perugia University Medical School, Perugia, Italy.
  • Cheng A; Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada.
  • Charbonnel B; Nantes University, Nantes, France.
  • Aroda VR; Division of Endocrinology, Hypertension, and Diabetes, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Westerbacka J; Sanofi, Paris, France.
  • Bosnyak Z; Sanofi, Paris, France.
  • Boëlle-Le Corfec E; Sanofi, Paris, France.
  • Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, Texas, USA.
Diabetes Obes Metab ; 23(7): 1588-1593, 2021 07.
Article em En | MEDLINE | ID: mdl-33687748
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2021 Tipo de documento: Article